Company profile

Wenemea company profile

Wenemea is the developer of chemotherapy-induced peripheral neuropathy designed for cancer treatment through neurological screening.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
00001-00010 employees
Founded
2023-01-01

Headquarters

Headquarters
Århus, Central Jutland, Denmark
Postal code
8000
Country code
DK
Continent
Europe

Capital profile

Funding and company signals

Funding rounds
1
Last funding
Grant / $1.1M / 2026-01-21
Investors
1
Lead investors
1

Categories and groups

Founders and investors

Lead investors

Eurostars

Investors

Eurostars

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.